DR. JEAN JEUDY, M.D.
Radiology at Greene St, Baltimore, MD

License number

Maryland D61823

Professional information

See more information about JEAN JEUDY at trustoria.com

Associate Professor, Diagnostic Radiology (Cardiovascular &Amp; Pulmonary Imaging)

Location:

Baltimore, Maryland Area

Industry:

Medical Practice

Jean Jeudy, Baltimore MD

Specialties:

Radiologist

Address:

22 S Greene St, Baltimore, MD 21201

Education:

Doctor of Medicine*

Board certifications:

American Board of Radiology Certification in Diagnostic Radiology (Radiology)*

Jean Jeudy, Gwynn Oak MD

Specialties:

Nuclear Medicine, Radiology, Diagnostic Radiology

Work:

Kernan Hospital
2200 Kernan Dr, Gwynn Oak, MD 21207 University of Maryland
22 S Greene St, Baltimore, MD 21263

Education:

University of Maryland(1998)

Dr. Jean Jeudy, Baltimore MD - MD (Doctor of Medicine)

Specialties:

Diagnostic Radiology

Address:

University Imaging Center
419 W Redwood St SUITE 110, Baltimore 21201
(410) 328-3225 (Phone)

Certifications:

Diagnostic Radiology, 2004

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

University Imaging Center
419 W Redwood St SUITE 110, Baltimore 21201
University of Maryland Medical Center
22 South Greene St, Baltimore 21201

Education:

Medical School
University Of Maryland School Of Medicine
Graduated: 1998

Gold Nanoparticle Imaging Agents And Uses Thereof

US Patent:

2011011, May 12, 2011

Filed:

Nov 12, 2010

Appl. No.:

12/927323

Inventors:

Omer Aras - Baltimore MD, US
Thorsten Fleiter - Owings Mills MD, US
Jean Jeudy - Baltimore MD, US
Marie-Christine Daniel - Catonsville MD, US

International Classification:

A61K 49/00, C07D 207/16, A61K 49/04, A61K 49/06, B32B 5/16, B82Y 15/00

US Classification:

424 91, 548533, 424 944, 424 93, 428402, 977773, 977810, 977927, 977928, 977930

Abstract:

Overexpression of angiotensin-converting enzyme (ACE) has been associated with a number of pathophysiologies, including those associated with cancer and the cardiovascular system. Thus, targeted imaging of ACE is of crucial importance for monitoring tissue ACE activity as well as treatment efficacy. To this end, lisinopril-coated gold nanoparticles were prepared to provide a new type of probe for targeted molecular imaging of ACE by tuned K-edge computed tomography (CT) imaging.